Skip to main content

House Bill

H.R. 5206

119th Congress

Empowering Striking Workers Act of 2025

In Committee
Introduced:Sep 8, 2025

Primary Sponsor

Donald W. Norcross

Donald W. Norcross

Representative

Democratic
NJ-1

Cosponsors

2

Quick Stats

Policy Area

Taxation

Summary

This bill would allow small businesses with less than $1 million in gross receipts that are doing research on medical countermeasures, like drugs or devices to prevent harm from health threats, to get a tax credit that they can receive as a refund even if they don't owe any taxes.

Latest Action

Referred to the House Committee on Ways and Means.

SponsorDonald W. Norcross (D-NJ)
Introduced9/8/2025
StatusReferred to the House Committee on Ways and Means.
ChamberHouse
Data from Congress.gov

See this page through your district lens

Enter ZIP to personalize representatives and vote context.

Stay on top of this issue

Subscribe for weekly bill and representative updates.

Vote Prediction

Empowering Striking Workers Act of 2025

This bill would allow small businesses with less than $1 million in gross receipts that are doing research on medical countermeasures, like drugs or devices to prevent harm from health threats, to get a tax credit that they can receive as a refund even if they

Community Breakdown

Pass

0%

Fail

0%

0 predictions

This bill would allow small businesses with less than $1 million in gross receipts that are doing research on medical countermeasures, like drugs or devices to prevent harm from health threats, to get a tax credit that they can receive as a refund even if they don't owe any taxes.

Bill Number
5206
Sponsor
Donald W. Norcross (D-NJ)
Introduced
9/8/2025
Status
Referred to the House Committee on Ways and Means.
Policy Area
Taxation

Data from Congress.gov

AI-generated summary

Fact Sheet

Title
Empowering Striking Workers Act of 2025
Bill Number
5206
Sponsor
Donald W. Norcross (D-NJ)
Status
Referred to the House Committee on Ways and Means.
Introduced
9/8/2025
Summary
This bill would allow small businesses with less than $1 million in gross receipts that are doing research on medical countermeasures, like drugs or devices to prevent harm from health threats, to get a tax credit that they can receive as a refund even if they don't owe any taxes.

Data from Congress.gov

Public Opinions

Community submissions related to this bill.

Share your opinion

No public opinions yet. Be the first to submit one for this bill.